THE PROTECTIVE PROPERTIES OF SEVOFLURANE AT ISCHEMIA-REPERFUSION INJURY OF TRANSPLANTED CADAVERIC KIDNEY
https://doi.org/10.15825/1995-1191-2015-4-40-45
Abstract
The paper presents the renoprotective properties of sevoflurane and propofol in kidney transplantation. In order to study these properties microdialysis technology was used. The study included 40 patients. The patients were randomized in two groups. Sevoflurane had more effective renoprotective properties than propofol.
About the Authors
M. Sh. Khubutia
N.V. Sklifosovsky Clinical and Research Institute for Emergency Medicine, Moscow, Russian Federation
Russian Federation
Russian Federation
S. V. Zhuravel
N.V. Sklifosovsky Clinical and Research Institute for Emergency Medicine, Moscow, Russian Federation
Russian Federation
Russian Federation
I. I. Utkina
N.V. Sklifosovsky Clinical and Research Institute for Emergency Medicine, Moscow, Russian Federation
Russian Federation
Russian Federation
A. V. Pinchuk
N.V. Sklifosovsky Clinical and Research Institute for Emergency Medicine, Moscow, Russian Federation
Russian Federation
Russian Federation
N. K. Kuznetsova
N.V. Sklifosovsky Clinical and Research Institute for Emergency Medicine, Moscow, Russian Federation
Russian Federation
Russian Federation
References
1. Messa P, Ponticelli C, Berardinelli L. Coming back to dialysis after kidney transplant failure. Nephrol Dial Transplant. 2008; 23; 9: 2738–2742.
2. Danobeitia JS, Djamali A, Fernandez LA. The role of complement in the pathogenesis of renal ischemia-reperfusion injury and fibrosis. Fibrogenesis Tissue Repair. 2014; 7: 16.
3. Khalid U, Bowen T, Fraser DJ, Jenkins RH. Acute kidney injury: a paradigm for miRNA regulation of the cell cycle. Biochem Soc Trans. 2014; 42; 4: 1219–1223.
4. Rong S, Hueper K, Kirsch T. Renal PKC-ε deficiency attenuates acute kidney injury and ischemic allograft injury via TNF-α-dependent inhibition of apoptosis and inflammation. Am J Physiol Renal Physiol. 2014; 307; 6: 718–726.
5. Cao Z, Zhang G, Wang F. Protective effects of mesenchymal stem cells with CXCR4 up-regulation in a rat renal transplantation model. PLoS One. 2013; 8; 12: 829–849.
6. Shokeir A, Barakat N, Hussein A. Activation of Nrf2 by ischemic preconditioning and sulforaphane in renal ischemia/reperfusion injury: a comparative experimental study. Physiol Res. 2015; 64 (3): 313–23. PMID: 25536319.
7. Liang Y, Li Z, Mo N. Isoflurane preconditioning ameliorates renal ischemia-reperfusion injury through antiinflammatory and antiapoptotic actions in rats. Biol Pharm Bull. 2014; 37; 10: 1599–1605.
8. Qin Z, Lv E, Zhan L. Intravenous pretreatment with emulsified isoflurane preconditioning protects kidneys against ischemia/reperfusion injury in rats. BMC Anesthesiol. 2014; 14: 28–30.
9. Хубутия МШ, Журавель СВ, Романов АА. Ранняя оценка функции почечного аллотрансплантата в периоперационном периоде методом микродиализа. Трансплантология. 2014; 1: 20–23. Hubutija MS, Zhuravel' SV, Romanov AA. Rannjaja ocenka funkcii pochechnogo allotransplantata v perioperacionnom periode metodom mikrodializa. Transplantologija. 2014; 1: 20–23.
10. Cekauskas A, Bruns H, Manikas M. Sulforaphane decreases kidney injury after transplantation in rats: role of mitochondrial damage Ann Transplant. 18: 488–496.
11. Zhou S, Jiang P, Liu L, Liu H. Protective effect of sevoflurane on hepatic ischaemia/reperfusion injury in the rat: A dose-response study. Eur J Anaesthesiol. 2013; 30 (10): 612–617. doi: 10.1097/EJA.0b013e3283614023.
12. Soro M, Gallego L, Silva V. Cardioprotective effect of sevoflurane and propofol during anaesthesia and the postoperative period in coronary bypass graft surgery: a double-blind randomised study. Eur J Anaesthesiol. 2012; 29; 12: 561–569.
13. Zhang J, Wang C, Yu S. Sevoflurane postconditioning protects rat hearts against ischemia-reperfusion injury via the activation of PI3K/AKT/mTOR signaling. Sci Rep. 2014; 4: 71–73.
14. Bettex D, Wanner P, Bosshart M. Role of sevoflurane in organ protection during cardiac surgery in children: a randomized controlled trial. Interact Cardiovasc Thorac Surg. 2015; 20; 2: 157–165.
15. Fudickar A, Kunath S, Voß D. Effect of ischemic and pharmacological preconditioning of lower limb muscle tissue on tissue oxygenation measured by near-infrared spectroscopy – a pilot study. BMC Anesthesiol. 2014; 14: 54–57.
16. Лихванцев ВВ, Мороз ВВ, Гребенчиков ОА. Ишемическое и фармакологическое прекондиционирование. Общая реаниматология. 2012; 1: 61–66. Lihvancev VV, Moroz VV, Grebenchikov OA. Ishemicheskoe i farmakologicheskoe prekondicionirovanie. Obshсhaja reanimatologija. 2012; 1: 61–66.
17. Мороз ВВ, Борисов КЮ, Гребенчиков ОА. Анестетическое прекондиционирование миокарда и некоторые биохимические маркеры сердечной и коронарной недостаточности после операций аортокоронарного шунтирования. Общая реаниматология. 2013; 5: 29–35. Moroz VV, Borisov KJ, Grebenchikov OA. Anesteticheskoe prekondicionirovanie miokarda i nekotorye biohimicheskie markery serdechnoj i koronarnoj nedostatochnosti posle operacij aortokoronarnogo shuntirovanija. Obshсhaja reanimatologija. 2013; 5: 29–35.
18. Beck-Schimmer B, Breitenstein S, Bonvini J. Protection of pharmacological postconditioning in liver surgery: results of a prospective randomized controlled trial. Ann Surg. 2012; 256; 5: 837–844.
19. Lucchinetti E, Ambrosio S, Aguirre J. Sevoflurane inhalation at sedative concentrations provides endothelial protection against ischemia-reperfusion injury in humans. Anesthesiology. 2007; 106; 2: 262–268.
20. Swyers T, Redford D, Larson D. Volatile anesthetic-induced preconditioning. Perfusion. 2014; 29; 1: 10–15.
21. Movafagh S, Crook S, Vo KJ. Regulation of HypoxiaInducible Factor-1a by Reactive Oxygen Species: New Developments in an Old Debate. Cell Biochem. 2015; 116 (5): 696–703. doi: 10.1002/jcb.25074.
22. Bocanegra V, Gil Lorenzo AF, Cacciamani V. RhoA and MAPK signal transduction pathways regulate NHE1-dependent proximal tubule cell apoptosis after mechanical stretch. Am J Physiol Renal Physiol. 2014; 307; 7: 881–889.
23. Wang H, Liu S, Wang H. The effect of propofol postconditioning on the expression of KCl co-transporter 2 in GABAergic inhibitory interneurons of acute ischemia/ reperfusion injury rats Brain Res. 2015; 1597: 210–219. doi: 10.1016/j.brainres.2014.11.036.
24. Mahajan C, Chouhan RS, Rath GP. Effect of intraoperative brain protection with propofol on postoperative cognition in patients undergoing temporary clipping during intracranial aneurysm surgery. Neurol India. 2014; 62; 3: 262–268.
25. Jovic M, Stancic A, Nenadic D. Mitochondrial molecular basis of sevoflurane and propofol cardioprotection in patients undergoing aortic valve replacement with cardiopulmonary bypass. Cell Physiol Biochem. 2012; 29; 2: 131–142.
26. Schifilliti D, Grasso G, Conti A. Anaesthetic-related neuroprotection: intravenous or inhalational agents. CNS Drugs. 2010; 24; 11: 893–907.
27. Bruhl SR, Vetteth S, Rees M. Post-reperfusion syndrome during renal transplantation: a retrospective study. Int J Med Sci. 2012; 9; 5: 391–396.
28. Nafar M, Sahraei Z, Salamzadeh J. Oxidative stress in kidney transplantation: causes, consequences, and potential treatment. Iran J Kidney Dis. 2011; 5; 6: 357–372.
29. Snoeijs MG, Bijnen A, Swennen E. Tubular epithelial injury and inflammation after ischemia and reperfusion in human kidney transplantation. Ann Surg. 2011; 253; 3: 598–604.
30. Журавель СВ, Романов АА, Гончарова ИИ. Перспективы применения микродиализной технологии в клинической трансплантологии. Высокотехнологичная медицина. 2014; 1: 24–29. Zhuravel' SV, Romanov AA, Goncharova II. Perspektivy primenenija mikrodializnoj tehnologii v klinicheskoj transplantologii. Vysokotehnologichnaja medicina. 2014; 1: 24–29.
Review
For citations:
Khubutia M.Sh., Zhuravel S.V., Utkina I.I., Pinchuk A.V., Kuznetsova N.K. THE PROTECTIVE PROPERTIES OF SEVOFLURANE AT ISCHEMIA-REPERFUSION INJURY OF TRANSPLANTED CADAVERIC KIDNEY. Russian Journal of Transplantology and Artificial Organs. 2015;17(4):40-45. (In Russ.) https://doi.org/10.15825/1995-1191-2015-4-40-45
Views:
1163
Email this article 